Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Thoracic 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 9Uterine Cervical Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 1Skin Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Heart Diseases 1Endometrial Neoplasms 1Disease 1Atrial Fibrillation 1Arrhythmias, Cardiac 1

Interventions

Paclitaxel 26pembrolizumab 24Docetaxel 20Capecitabine 19Fulvestrant 17Trastuzumab 16Anastrozole 15Cyclophosphamide 14Lapatinib 13Letrozole 11Carboplatin 11Radiotherapy 10Doxorubicin 10palbociclib 9Therapeutics 9Nivolumab 9Exercise 9Gemcitabine 8Cisplatin 8Blood Specimen Collection 8Tamoxifen 7Bevacizumab 7liposomal doxorubicin 6exemestane 6abemaciclib 6Vinorelbine 6Standard of Care 6Fluorouracil 6atezolizumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Mass Screening × Breast × Clear all
NCT00859768 2011-03-08

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Netherlands Open University

Phase NA Completed
568 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡